Live News Categoriesmarket

MCRB.O (MCRB.O) News

Follow MCRB.O (MCRB.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol MCRB.O Asset market Sector Markets 90 days 1 Updated Oct 15, 2026, 11:08 AM UTC Open live news feed

L Seres Therapeutics' SER — 428 reduces gut pathogens up to 1,000 — fold in preclinical studies Seres Therapeutics reported SER-428 reduced gastrointestinal Enterococcus faecium and Klebsiella pneumoniae abundance by up to 1,000-fold in preclinical models. The investigational liquid live biotherapeutic targets bloo EQUITY | Oct 15, 2026, 11:08 AM UTC